Substituting adjuvant trastuzumab emtansine for Herceptin improves survival in patients with human epidermal growth factor receptor 2–positive breast cancer

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Adjuvant trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: Take-home points from the KATHERINE trial

The National Medical Journal of India ◽

10.4103/0970-258x.314006 ◽

2020 ◽

Vol 33 (3) ◽

pp. 158

Author(s):

Atul Batra ◽

Ilavarasi Vanidassane ◽

RamavathDevendra Naik ◽

Vinod Sharma ◽

Sachin Khurana

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer

npj Precision Oncology ◽

10.1038/s41698-020-00128-1 ◽

2020 ◽

Vol 4 (1) ◽

Author(s):

Ke-Da Yu ◽

Xin Wang ◽

Wan-Kun Chen ◽

Lei Fan ◽

Miao Mo ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2016.04.004 ◽

2016 ◽

Vol 27 (2) ◽

pp. 160-161

Author(s):

R. Gopal

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Locoregional Recurrence ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Ado-trastuzumab emtansine – The monoclonal drug conjugate in human epidermal growth factor receptor 2-positive breast cancer

Indian Journal of Medical and Paediatric Oncology ◽

10.4103/ijmpo.ijmpo_246_19 ◽

2020 ◽

Vol 41 (2) ◽

pp. 218

Author(s):

Sandip Ganguly ◽

Joydeep Ghosh ◽

Bivas Biswas ◽

Deepak Dabkara

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Drug Conjugate ◽

Epidermal Growth ◽

High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab

Cancer Management and Research ◽

10.2147/cmar.s231444 ◽

2020 ◽

Vol Volume 12 ◽

pp. 475-484 ◽

Cited By ~ 1

Author(s):

Li Jiang ◽

Jianjiang Fang ◽

Jinhua Ding

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Poor Survival ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy

Annals of Surgical Oncology ◽

10.1245/s10434-014-4321-2 ◽

2015 ◽

Vol 22 (8) ◽

pp. 2517-2525 ◽

Cited By ~ 20

Author(s):

Ryan M. Lanning ◽

Monica Morrow ◽

Nadeem Riaz ◽

Heather L. McArthur ◽

Chau Dang ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Locoregional Recurrence ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer

Expert Opinion on Biological Therapy ◽

10.1517/14712598.2015.1036026 ◽

2015 ◽

Vol 15 (5) ◽

pp. 749-760 ◽

Cited By ~ 4

Author(s):

Tom Van den Mooter ◽

Laure-Anne Teuwen ◽

Annemie Rutten ◽

Luc Dirix

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Epidermal Growth ◽

Abstract P3-14-04: Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer

10.1158/1538-7445.sabcs19-p3-14-04 ◽

2020 ◽

Author(s):

Ke-Da Yu ◽

Zhi-Rui Zhou ◽

Zhi-Ming Shao

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Early Human ◽

Trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer

Current Opinion in Oncology ◽

10.1097/cco.0b013e32834b895c ◽

2011 ◽

Vol 23 (6) ◽

pp. 594-600 ◽

Cited By ~ 33

Author(s):

Jacob Mathew ◽

Edith A. Perez

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Epidermal Growth ◽

Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2–positive breast cancer

Hong Kong Medical Journal ◽

10.12809/hkmj176808 ◽

2018 ◽

Cited By ~ 1

Author(s):

Winnie Yeo ◽

◽

MY Luk ◽

Inda S Soong ◽

Tony YS Yuen ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Trastuzumab Emtansine ◽

Epidermal Growth ◽